Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Decode Genetics Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Decode Genetics Inc since year 2005.
Table 2 shows the detailed insider transactions of Decode Genetics Inc since 2005.
The reporting company's ticker symbol is DCGN. The reporting company's CIK number is 1022974.
The total value of stock buying since 2005 is $3,280.
The total value of stock sales since 2005 is $49,961.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2008-09-16||Sigurdsson Jakob O (S.V.P., Corporate Development)||Sale||1,871||.65||1,216|
|2007-06-05||Gurney Mark (Sr. VP Drug Discovery & Dvpmt)||Buy||1,000||3.28||3,280|
|2005-08-24||Hakonarson Hakon (V.P., Clinical Studi)||Sale||5,000||9.75||48,745|
Insider trading activities including stock purchases, stock sales, and option exercises of DCGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Decode Genetics Inc (symbol DCGN, CIK number 1022974) see the Securities and Exchange Commission (SEC) website.